January 1, 1989Thrombosis and Haemostasis
Risks to the Fetus of Anticoagulant Therapy During Pregnancy
View Full Paper
Ask AI
Bookmark
Share
Key result
No clinical data is available in the provided text, which consists only of the journal's editorial board information.
Why the study?
Does anticoagulant therapy during pregnancy increase adverse fetal/infant outcomes?
Population
1,325 pregnancies associated with anticoagulant therapy from 186 reports
Comparison
Anticoagulant therapy vs Normal population
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
The previously reported high rate of adverse fetal outcomes with heparin during pregnancy is likely due to underlying maternal comorbid conditions rather than the drug itself.
Structured PICO
Does anticoagulant therapy during pregnancy increase adverse fetal/infant outcomes?
P
Population
1,325 pregnancies associated with anticoagulant therapy from 186 reports
E
Exposure
Anticoagulant therapy (heparin, oral anticoagulants, or both)
C
Comparator
Normal population
O
Outcome
Adverse fetal/infant outcomes including death, prematurity and congenital malformationssafety
The previously reported high rate of adverse fetal outcomes with heparin during pregnancy is likely due to underlying maternal comorbid conditions rather than the drug itself.
Cite This Study
Ginsberg et al. (1989) studied Anticoagulant Therapy During Pregnancy. Anticoagulant Therapy was evaluated. No clinical data is available in the provided text, which consists only of the journal's editorial board information.
Topics
View Full Paper
Ask AI
Bookmark
Share